chemotherapy: be used with radiation

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents treatment
Weight: 0.64
, regimen
Weight: 0.62
, modality
Weight: 0.61
, agent
Weight: 0.60
, prostate cancer
Weight: 0.59
Siblings gene therapy
Weight: 0.66
, breast cancer
Weight: 0.36
, dialysis
Weight: 0.36
, transplant
Weight: 0.34
, mastectomy
Weight: 0.34

Related properties

Property Similarity
be used with radiation 1.00
be given before radiation 0.94
be vs radiation 0.89

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Salient implies Plausible

0.23
Rule weight: 0.28
Evidence weight: 0.81
Similarity weight: 1.00
Evidence: 0.66
Plausible(chemotherapy, be used with radiation)
Evidence: 0.55
¬ Salient(chemotherapy, be used with radiation)

Similarity expansion

0.78
Rule weight: 0.85
Evidence weight: 0.97
Similarity weight: 0.94
Evidence: 0.96
Remarkable(chemotherapy, be used with radiation)
Evidence: 0.87
¬ Remarkable(chemotherapy, be given before radiation)
0.73
Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 0.89
Evidence: 0.96
Remarkable(chemotherapy, be used with radiation)
Evidence: 0.97
¬ Remarkable(chemotherapy, be vs radiation)
0.71
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.89
Evidence: 0.02
Typical(chemotherapy, be used with radiation)
Evidence: 0.06
¬ Typical(chemotherapy, be vs radiation)
0.68
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.89
Evidence: 0.66
Plausible(chemotherapy, be used with radiation)
Evidence: 0.29
¬ Plausible(chemotherapy, be vs radiation)
0.57
Rule weight: 0.85
Evidence weight: 0.71
Similarity weight: 0.94
Evidence: 0.02
Typical(chemotherapy, be used with radiation)
Evidence: 0.30
¬ Typical(chemotherapy, be given before radiation)
0.57
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.89
Evidence: 0.55
Salient(chemotherapy, be used with radiation)
Evidence: 0.56
¬ Salient(chemotherapy, be vs radiation)
0.56
Rule weight: 0.85
Evidence weight: 0.70
Similarity weight: 0.94
Evidence: 0.66
Plausible(chemotherapy, be used with radiation)
Evidence: 0.88
¬ Plausible(chemotherapy, be given before radiation)
0.54
Rule weight: 0.85
Evidence weight: 0.67
Similarity weight: 0.94
Evidence: 0.55
Salient(chemotherapy, be used with radiation)
Evidence: 0.74
¬ Salient(chemotherapy, be given before radiation)

Typical and Remarkable implies Salient

0.14
Rule weight: 0.14
Evidence weight: 0.99
Similarity weight: 1.00
Evidence: 0.55
Salient(chemotherapy, be used with radiation)
Evidence: 0.02
¬ Typical(chemotherapy, be used with radiation)
Evidence: 0.96
¬ Remarkable(chemotherapy, be used with radiation)

Typical implies Plausible

0.47
Rule weight: 0.48
Evidence weight: 0.99
Similarity weight: 1.00
Evidence: 0.66
Plausible(chemotherapy, be used with radiation)
Evidence: 0.02
¬ Typical(chemotherapy, be used with radiation)